Table 3.
Case/Total | Incidence rate, per 1000 person-years | Model 1 | Model 2 | Model 3 | |
---|---|---|---|---|---|
Q1 | 891/12003 | 8.80 | 1.00 | 1.00 | 1.00 |
Q2 | 933/12003 | 9.18 | 1.05(0.96,1.15) | 1.04(0.95,1.14) | 1.04(0.95,1.14) |
Q3 | 1042/12004 | 10.28 | 1.19(1.09,1.30) | 1.16(1.06,1.27) | 1.13(1.03,1.24) |
Q4 | 1189/12003 | 11.70 | 1.39(1.27,1.51) | 1.34(1.23,1.47) | 1.18(1.08,1.29) |
1-SD increase (0.22) | 1.20(1.09,1.15) | 1.11(1.08,1.15) | 1.04(1.01,1.07) | ||
P for Trend | <0.0001 | <0.0001 | <0.0001 |
Model 1: adjusted for age (continuous variable, years) and sex (categorical variable, men or women) in 2010.
Model2: included variables in model 1 and further LDL-C (as a continuous variable), HDL-C (as a continuous variable), hs-CRP (as a continuous variable), BMI (as a continuous variable), smoking status (as a categorical variable, yes or no), alcohol consumption status (as a categorical variable, yes or no), physical exercise habits (as a categorical variable, yes or no), educational level (as a categorical variable, high school or above vs. below high school level), hypertension (as a categorical variable, yes or no), and the use of lipid-lowering drugs (as a categorical variable, yes or no) in 2010.
Model 3: included variables in model 2 and further the TyG index (continuous variable) in baseline.